In conclusion, the relationship between vitamin D blood levels and the development of arthralgia in women with breast cancer under aromatase inhibitor treatment remains unclear, as well as the potential use of vitamin D supplementation to reduce this side effect. The gene discussed is CYP19A1; the disease is breast cancer.